Clinical Trial Update: Effect of Acetazolamide on Central Sleep Apnea Related to Opium Consumption [Phase 4]

View source ↗

Summary

This clinical trial update describes a Phase 4 study evaluating acetazolamide for central sleep apnea related to opium consumption.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Central Sleep Apnea

Drugs mentioned

• ACETAZOLAMIDE (acetazolamide)

Snippet

Sponsor: Shahid Beheshti University of Medical Sciences | Conditions: Central Sleep Apnea, Secondary | Phase 4 | Status: UNKNOWN